Thermalytix

JSON twin: https://www.healthaidb.com/software/thermalytix.json

Company Name

Niramai

Product URL

https://www.niramai.com/about/thermalytix/

Company URL

https://www.niramai.com

Categories

• diagnostic Support
• clinical Care
• patient Facing
• Diagnostic
• Clinical

Summary

Thermalytix is an AI-powered, non-invasive breast cancer screening solution developed by Niramai, utilizing high-resolution thermal imaging for early and accurate detection.

Description

Thermalytix is a computer-aided diagnostic engine that employs artificial intelligence to analyze thermal images for reliable, early, and accurate breast cancer screening. It uses a high-resolution thermal sensing device and a cloud-hosted analytics solution to process thermal images. The solution has been used by over 250,000 women in more than 250 hospitals and diagnostic centers across 20+ countries, including India, UAE, Kenya, Philippines, Sweden, Bulgaria, and the USA. Thermalytix has obtained CE Mark certification for all European countries and regulatory clearance in the aforementioned countries. The product is compliant with ISO 13485 and MDSAP quality management processes and adheres to information security and data privacy policies as per EU GDPR, ISO 27001, and US HIPAA requirements. Multiple clinical studies have demonstrated that Thermalytix's accuracy is comparable to X-ray mammography and 25% more sensitive in women with dense breasts. The solution has been granted 32 patents, including 11 US patents and others in Europe, Japan, Singapore, China, and Canada.

Api Available

unknown

Certifications

• CE Mark
• FDA clearance for SMILE-100 (BreastHealth-100) device

Company Founding

2016

Company Offices

• India
• United Kingdom
• United States
• Sweden
• Bulgaria
• Kenya
• Philippines
• United Arab Emirates
• China
• Japan

Compliance

• ISO 13485
• MDSAP
• ISO 27001
• EU GDPR
• US HIPAA

Customers

Data Residency

Global availability with compliance to regional data protection laws

Data Standards

• DICOM
• HL7
• FHIR

Deployment Model

• SaaS
• on_prem
• hybrid

Features

• AI-powered breast cancer screening
• High-resolution thermal sensing device
• Cloud-hosted analytics solution
• Automated analysis of thermal images
• Quantitative breast health scoring
• Detection of subtle temperature abnormalities
• Adaptable AI algorithms improving over time
• Non-inferior sensitivity to conventional mammography
• Suitable for women of all age groups and breast densities
• Portable and affordable screening method
• Suitable for large-scale public health programs
• Suitable for corporate wellness initiatives
• Integration with existing diagnostic imaging
• Radiation-free screening process
• No-touch, no-see approach
• Early detection of breast abnormalities
• Reduced subjectivity and human error
• Consistent and reproducible results
• Enhanced thermal sensitivity compared to traditional thermography

Id

SW2689

Integration Partners

Integrations

• Mammography
• Ultrasound
• MRI
• SMILE-100 (BreastHealth-100) device

Languages Supported

• English
• Hindi
• Malayalam
• Swedish
• Bulgarian
• Filipino
• Swahili
• Arabic

Last Updated

2025-10-11

License

commercial

Market Segment

• enterprise
• consumer

Optional Modules

• SMILE-100 (BreastHealth-100) device with subset of Thermalytix functionality

Os Platforms

• Web
• iOS
• Android
• Windows
• macOS
• Linux

Pricing Details

Contact vendor for pricing information.

Pricing Model

subscription

Privacy Features

• Data anonymization
• Data minimization
• Compliance with data protection regulations
• User consent management

Product Code

SW2689

Product Name

Thermalytix

Ratings

Regions Available

• India
• United Arab Emirates
• Kenya
• Philippines
• Sweden
• Bulgaria
• United States
• European Economic Area
• Asia
• Africa
• Middle East

Related Urls

• https://www.niramai.co.uk/
• https://www.thermalytix.com/

Release Year

Security Features

• Data encryption at rest and in transit
• Role-based access control (RBAC)
• Audit logs
• Secure cloud infrastructure

Specialties

• Radiology
• Oncology

Support Channels

System Requirements

High-resolution thermal sensing device, cloud infrastructure for analytics

Target Users

• clinicians
• patients

Training Options

Type

product

User Reviews

Version

1.0

Alternatives

See related products

Canonical JSON

{
  "product_name": "Thermalytix",
  "company_name": "Niramai",
  "product_url": "https://www.niramai.com/about/thermalytix/",
  "company_url": "https://www.niramai.com",
  "related_urls": [
    "https://www.niramai.co.uk/",
    "https://www.thermalytix.com/"
  ],
  "product_code": "SW2689",
  "summary": "Thermalytix is an AI-powered, non-invasive breast cancer screening solution developed by Niramai, utilizing high-resolution thermal imaging for early and accurate detection.",
  "description": "Thermalytix is a computer-aided diagnostic engine that employs artificial intelligence to analyze thermal images for reliable, early, and accurate breast cancer screening. It uses a high-resolution thermal sensing device and a cloud-hosted analytics solution to process thermal images. The solution has been used by over 250,000 women in more than 250 hospitals and diagnostic centers across 20+ countries, including India, UAE, Kenya, Philippines, Sweden, Bulgaria, and the USA. Thermalytix has obtained CE Mark certification for all European countries and regulatory clearance in the aforementioned countries. The product is compliant with ISO 13485 and MDSAP quality management processes and adheres to information security and data privacy policies as per EU GDPR, ISO 27001, and US HIPAA requirements. Multiple clinical studies have demonstrated that Thermalytix's accuracy is comparable to X-ray mammography and 25% more sensitive in women with dense breasts. The solution has been granted 32 patents, including 11 US patents and others in Europe, Japan, Singapore, China, and Canada.",
  "categories": [
    "diagnostic Support",
    "clinical Care",
    "patient Facing",
    "Diagnostic",
    "Clinical",
    "Patient-facing"
  ],
  "market_segment": [
    "enterprise",
    "consumer"
  ],
  "target_users": [
    "clinicians",
    "patients"
  ],
  "specialties": [
    "Radiology",
    "Oncology"
  ],
  "regions_available": [
    "India",
    "UAE",
    "Kenya",
    "Philippines",
    "Sweden",
    "Bulgaria",
    "USA",
    "European Economic Area",
    "Asia",
    "Africa",
    "Middle East"
  ],
  "languages_supported": [
    "English",
    "Hindi",
    "Malayalam",
    "Swedish",
    "Bulgarian",
    "Filipino",
    "Swahili",
    "Arabic"
  ],
  "pricing_model": "subscription",
  "pricing_details": "Contact vendor for pricing information.",
  "license": "commercial",
  "company_offices": [
    "India",
    "United Kingdom",
    "United States",
    "Sweden",
    "Bulgaria",
    "Kenya",
    "Philippines",
    "UAE",
    "China",
    "Japan"
  ],
  "company_founding": "2016",
  "deployment_model": [
    "SaaS",
    "on_prem",
    "hybrid"
  ],
  "os_platforms": [
    "Web",
    "iOS",
    "Android",
    "Windows",
    "macOS",
    "Linux"
  ],
  "features": [
    "AI-powered breast cancer screening",
    "High-resolution thermal sensing device",
    "Cloud-hosted analytics solution",
    "Automated analysis of thermal images",
    "Quantitative breast health scoring",
    "Detection of subtle temperature abnormalities",
    "Adaptable AI algorithms improving over time",
    "Non-inferior sensitivity to conventional mammography",
    "Suitable for women of all age groups and breast densities",
    "Portable and affordable screening method",
    "Suitable for large-scale public health programs",
    "Suitable for corporate wellness initiatives",
    "Integration with existing diagnostic imaging",
    "Radiation-free screening process",
    "No-touch, no-see approach",
    "Early detection of breast abnormalities",
    "Reduced subjectivity and human error",
    "Consistent and reproducible results",
    "Enhanced thermal sensitivity compared to traditional thermography"
  ],
  "optional_modules": [
    "SMILE-100 (BreastHealth-100) device with subset of Thermalytix functionality"
  ],
  "integrations": [
    "Mammography",
    "Ultrasound",
    "MRI",
    "SMILE-100 (BreastHealth-100) device"
  ],
  "data_standards": [
    "DICOM",
    "HL7",
    "FHIR"
  ],
  "api_available": "unknown",
  "system_requirements": "High-resolution thermal sensing device, cloud infrastructure for analytics",
  "compliance": [
    "ISO 13485",
    "MDSAP",
    "ISO 27001",
    "EU GDPR",
    "US HIPAA"
  ],
  "certifications": [
    "CE Mark",
    "FDA clearance for SMILE-100 (BreastHealth-100) device"
  ],
  "security_features": [
    "Data encryption at rest and in transit",
    "Role-based access control (RBAC)",
    "Audit logs",
    "Secure cloud infrastructure"
  ],
  "privacy_features": [
    "Data anonymization",
    "Data minimization",
    "Compliance with data protection regulations",
    "User consent management"
  ],
  "data_residency": "Global availability with compliance to regional data protection laws",
  "customers": [],
  "user_reviews": [],
  "ratings": [],
  "support_channels": [],
  "training_options": [],
  "release_year": "",
  "integration_partners": [],
  "id": "SW2689",
  "slug": "thermalytix",
  "type": "product",
  "version": "1.0",
  "last_updated": "2025-10-11",
  "links_json": {
    "self": "https://www.healthaidb.com/software/thermalytix.json"
  }
}